scd-101
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2015 (NCT02380079)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- scd-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02380079 | Phase 1 | Feb 1, 2015 | Invenux, LLC, Kings County Medical Center, State University of New York, Brooklyn |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Invenux, LLC | For profit | 1 | 1 | 1 | 2015 |
| Kings County Medical Center | Academic/Hospital | 1 | 0 | 1 | 2015 |
| State University of New York, Brooklyn | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1